Stonepine Capital Management, LLC
Bend, OR · CIK 1440771 · 13F filing filed 2026-08-17
SEC-registered investment adviser since 2026 · limited liability company
- Assets managed$181.0m
- Staff4 · 3 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $181.0m gross assets
- Websitestonepinecap.com
- Form ADV · 2026-06-26SEC adviser record
- Legal entitySTONEPINE CAPITAL MANAGEMENT, LLC (US)
$131.4m
reported value
+15.5% vs Q1 2026
72positions
55.3%in top 10
19 new
23 added
25 reduced
13 sold out
vs Q1 2026
Options: 15 call positions ($45.9m notional), 0 put positions (— notional) – listed below, not included above.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| VERASTEM INC VSTM | $12.8m9.74% | Added +47.3k |
| EVOLUS INC EOLS | $11.0m8.40% | Reduced -168.9k |
| TENAX THERAPEUTICS INC TENX | $9.6m7.31% | Reduced -315.2k |
| NEKTAR THERAPEUTICS NKTR | $8.4m6.41% | Added +35.7k |
| ADMA BIOLOGICS INC ADMA | $6.2m4.72% | Unchanged |
| CAMP4 THERAPEUTICS CORP CAMP | $6.1m4.62% | Unchanged |
| ELOXX PHARMACEUTICALS INC ELOX | $5.5m4.20% | New |
| KAZIA THERAPEUTICS LTD KZIA | $4.9m3.70% | Unchanged |
| INDIVIOR PHARMACEUTICALS INC INDV | $4.1m3.12% | New |
| CORBUS PHARMACEUTICALS HLDGS CRBP | $4.0m3.03% | Added +41.5k |
| SATELLOS BIOSCIENCE INC MSLE | $3.7m2.83% | Added +391.6k |
| ZEVRA THERAPEUTICS INC ZVRA | $3.7m2.82% | Reduced -221.3k |
| ABEONA THERAPEUTICS INC ABEO | $3.4m2.62% | Reduced -189.3k |
| EDESA BIOTECH INC EDSA | $3.2m2.43% | Added +426.4k |
| CABALETTA BIO INC CABA | $2.9m2.17% | Added +867.1k |
| AN2 THERAPEUTICS INC ANTX | $2.7m2.03% | Reduced -162.2k |
| XILIO THERAPEUTICS INC XLO | $2.2m1.65% | Added +161.8k |
| ADICET BIO INC ACET | $2.1m1.61% | Added +23.6k |
| TELA BIO INC TELA | $2.0m1.52% | Added +45.2k |
| AYTU BIOPHARMA INC AYTU | $2.0m1.49% | Added +120.6k |
| CURIS INC COM | $1.7m1.32% | Reduced -414.2k |
| SPRUCE BIOSCIENCES INC SPRB | $1.6m1.18% | New |
| OKYO PHARMA LTD OKYO | $1.3m0.99% | Added +13.0k |
| PASITHEA THERAPEUTICS CORP KTTA | $1.1m0.86% | Added +1.4m |
| SOL-GEL TECHNOLOGIES LTD SLGL | $1.1m0.82% | Reduced -13.3k |
| PULMONX CORP LUNG | $1.1m0.81% | Added +47.1k |
| X4 PHARMACEUTICALS INC XFOR | $1.1m0.80% | Reduced -110.3k |
| IN8BIO INC INAB | $980.4k0.75% | Added +31.9k |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $973.5k0.74% | New |
| QUOIN PHARMACEUTICALS LTD QNRX | $965.5k0.74% | Added +146.0k |
| MAXCYTE INC MXCT | $924.5k0.70% | Reduced -253.1k |
| PHATHOM PHARMACEUTICALS INC PHAT | $922.4k0.70% | Added +35.0k |
| AZITRA INC AZTR | $886.9k0.68% | New |
| CONNECT BIOPHARMA HLDGS LTD CNTB | $866.9k0.66% | Added +54.3k |
| CYBIN INC COM NEW | $854.5k0.65% | Reduced -4.8k |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $834.8k0.64% | New |
| INHIBIKASE THERAPEUTICS INC IKT | $804.2k0.61% | Reduced -561.0k |
| ZENTALIS PHARMACEUTICALS INC ZNTL | $783.7k0.60% | Reduced -107.5k |
| CYTOMX THERAPEUTICS INC CTMX | $768.8k0.59% | Added +5.0k |
| NUVECTIS PHARMA INC NVCT | $735.6k0.56% | New |
| CRESCENT BIOPHARMA INC. CBIO | $720.0k0.55% | Reduced -45.0k |
| PMV PHARMACEUTICALS INC PMVP | $718.4k0.55% | Reduced -172.0k |
| ORUKA THERAPEUTICS INC ORKA | $713.8k0.54% | New |
| RADIOPHARM THERANOSTICS LTD RADX | $670.5k0.51% | Unchanged |
| ONKURE THERAPEUTICS INC OKUR | $595.9k0.45% | Reduced -1.9k |
| NERVGEN PHARMA CORP NGEN | $559.7k0.43% | New |
| CALCIMEDICA INC COM NEW | $544.9k0.41% | New |
| ARVINAS INC ARVN | $498.6k0.38% | Added +32.5k |
| BIOAGE LABS INC BIOA | $490.2k0.37% | Reduced -30.0k |
| OPUS GENETICS INC IRD | $414.0k0.32% | Added +32.0k |
| QT IMAGING HLDGS INC QTI | $407.0k0.31% | New |
| BOUNDLESS BIO INC BOLD | $386.5k0.29% | Reduced -443.1k |
| SINTX TECHNOLOGIES INC SINT | $332.5k0.25% | New |
| CELLECTAR BIOSCIENCES INC CLRB | $290.6k0.22% | New |
| EUPRAXIA PHARMACEUTICALS INC EPRX | $287.5k0.22% | New |
| SAB BIOTHERAPEUTICS INC SABS | $285.8k0.22% | Added +23.3k |
| ADLAI NORTYE LTD ANL | $279.0k0.21% | New |
| SENSEONICS HLDGS INC SENS | $276.5k0.21% | New |
| PLIANT THERAPEUTICS INC PLRX | $262.8k0.20% | Added +5.9k |
| CODEXIS INC CDXS | $247.8k0.19% | Reduced -308.3k |
| PRECISION OPTICS CORP INC MA POCI | $236.6k0.18% | Reduced -53.6k |
| UPSTREAM BIO INC UPB | $231.3k0.18% | Reduced -1.6k |
| REIN THERAPEUTICS INC RNTX | $226.8k0.17% | New |
| HERON THERAPEUTICS INC HRTX | $209.5k0.16% | Reduced -911.4k |
| CNS PHARMACEUTICALS INC CNSP | $198.7k0.15% | Reduced -19.4k |
| HUMACYTE INC HUMA | $180.5k0.14% | New |
| KALARIS THERAPEUTICS INC KLRS | $122.6k0.09% | Added +9.7k |
| PROCESSA PHARMACEUTICALS INC PCSA | $105.6k0.08% | Unchanged |
| BIOATLA INC BCAB | $68.0k0.05% | New |
| COMPUGEN LTD CGEN | $67.2k0.05% | Reduced -72.9k |
| OVID THERAPEUTICS INC OVID | $57.3k0.04% | Reduced -18.7k |
| EVAXION AS EVAX | $54.4k0.04% | Reduced -2.2k |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| XOMA ROYALTY CORPORATION XOMA | $2.2m69.5k shares |
| SURROZEN INC SRZN | $961.4k33.0k shares |
| VERRICA PHARMACEUTICALS INC VRCA | $527.6k99.7k shares |
| CANDEL THERAPEUTICS INC CADL | $502.2k102.5k shares |
| ESTABLISHMENT LABS HLDGS INC ESTA | $340.7k6.0k shares |
| JANUX THERAPEUTICS INC JANX | $278.0k20.0k shares |
| OMNIAB INC OABI | $257.6k164.0k shares |
| XERIS BIOPHARMA HOLDINGS INC XERS | $232.2k40.0k shares |
| NEUMORA THERAPEUTICS INC. NMRA | $195.0k100.0k shares |
| SI-BONE INC SIBN | $189.0k15.0k shares |
| ELEDON PHARMACEUTICALS INC ELDN | $107.8k35.0k shares |
| MANNKIND CORP MNKD | $39.9k16.3k shares |
| BIOATLA INC BCAB | $10.5k65.4k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| ADMA BIOLOGICS INC ADMA · Call | $8.0m650.0k shares | Reduced |
| INSMED INC INSM · Call | $5.6m40.0k shares | New |
| ULTRAGENYX PHARMACEUTICAL IN RARE · Call | $5.5m200.0k shares | New |
| MEDTRONIC PLC MDT · Call | $4.4m50.0k shares | New |
| ABBOTT LABS ABT · Call | $3.8m40.0k shares | New |
| BOSTON SCIENTIFIC CORP BSX · Call | $3.2m50.0k shares | New |
| EVOLUS INC EOLS · Call | $3.1m420.0k shares | Unchanged |
| BIOMARIN PHARMACEUTICAL INC BMRN · Call | $3.1m50.0k shares | New |
| XERIS BIOPHARMA HOLDINGS INC XERS · Call | $2.1m280.0k shares | Unchanged |
| SI-BONE INC SIBN · Call | $1.5m100.0k shares | Unchanged |
| HERON THERAPEUTICS INC HRTX · Call | $1.5m1.0m shares | Unchanged |
| NEUMORA THERAPEUTICS INC. NMRA · Call | $1.2m500.0k shares | Unchanged |
| ARDELYX INC ARDX · Call | $1.1m150.0k shares | Unchanged |
| DELCATH SYS INC DCTH · Call | $1.0m100.0k shares | Unchanged |
| MANNKIND CORP MNKD · Call | $750.0k250.0k shares | Reduced |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| QUOIN PHARMACEUTICALS LTD QNRX · 13G · filed 2026-05-15 | 10.0% |
| AEON BIOPHARMA INC AEON · 13G · filed 2026-07-21 | 9.9%≈ $3.9m |
| AZITRA INC 13G · filed 2026-06-22 | 9.9% |
| ELOXX PHARMACEUTICALS INC ELOX · 13G · filed 2026-06-16 | 9.9%≈ $5.6m |
| SINTX TECHNOLOGIES INC SINT · 13G · filed 2026-06-09 | 9.9%≈ $1.2m |
| CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-05-15 | 9.9%≈ $760.7k |
| CELLECTAR BIOSCIENCES INC CLRB · 13G · filed 2026-05-11 | 9.9%≈ $2.4m |
| CURIS INC 13G · filed 2026-03-27 | 9.9%≈ $2.1m |
| IN8BIO INC INAB · 13G · filed 2025-12-22 | 9.9%≈ $1.4m |
| AYTU BIOPHARMA INC AYTU · 13G · filed 2025-08-13 | 9.9%≈ $1.9m |
| OPTINOSE INC OPTN · 13G · filed 2025-05-14 | 7.8% |
| FEMASYS INC FEMY · 13G · filed 2026-08-31 | 7.2%≈ $2.6m |
| EDESA BIOTECH INC EDSA · 13G · filed 2026-08-26 | 6.9%≈ $5.9m |
| CALCIMEDICA INC 13G · filed 2026-08-25 | 6.0%≈ $2.2m |
| TELA BIO INC TELA · 13G · filed 2025-02-13 | 6.0%≈ $1.8m |
| PASITHEA THERAPEUTICS CORP KTTA · 13G · filed 2026-06-23 | 5.8%≈ $1.0m |